Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
We are very excited to launch our new website! Please take a few moments to click around and explore...